We are happy to announce that Pascal Sempé, Ph.D. has joined Medexprim as Senior Director Real-World Evidence.
A passionate healthcare and life sciences industry expert with a proven track record in biomedical science and information technology and services, Pascal played a pivotal role in the design and deployment of IBM’s Watson Health solutions for life sciences in Europe, the Middle East and Asia Pacific. He held several strategic roles in medical and pharmaceutical research organizations (J&J Pharmaceuticals Research Institute, Sanofi…), and helped leverage the potential of newly available Real-World data flows.
This expertise, combined with a rich network in the industry, will strengthen Medexprim’s ambition to accompany medical professionals in the improved use of Real-World data, and to support research and clinical development programs for the benefit of patients.
Romain Cazavan, CEO: “We have been fostering a multi-omic (clinical, genomics, imagomics) and multicentric European dataset strategy. The recruitment of such an expert in Real-World Data and Real-World Evidence leveraging Medexprim’s strategy will strengthen our role as a major partner to pharmaceutical companies.“
Pascal Sempé: “I am very enthusiastic to join Medexprim and to contribute to its international development for a better translation of Real-World Data into those Evidence that are so critical to accelerate biopharmaceutical research. Medexprim has a unique value proposition due to its expertise in aggregating disparate facets of rich medical data… But above all, what seduced me is that Medexprim was born deep inside the hospital, has established the necessary trust with the medical professionals, and can extract the value of medical data with the utmost consideration for the patient better than anyone else.”
REAL-WORLD EVIDENCE FOR BETTER CARE
Medexprim is Europe’s leading provider of secure imaging and clinical data extraction to accelerate medical research. As a real-world data specialist, we build bridges between leading academic hospitals and pharmaceutical, AI and medical device companies. In compliance with the GDPR, we help hospitals drive their own clinical research strategy and extract value from their data, through our software and services designed with and for clinicians. We provide our partners with secure access to regulatory-grade data. Medexprim aims to build multicentric disease-specific data lakes to serve oncology, neurology and cardiology. We help solve the “one patient, one disease, one treatment” equation to develop precision medicine for better care.
Medexprim Press contact: Anne-Sophie Labeta